skip to content »

Section of Atherosclerosis

Houston, Texas

BCM faculty, staff and trainees are the heart of the organization.
Section of Atherosclerosis and Vascular Medicine
not shown on screen

Ron C. Hoogeveen, Ph.D.


  • Assistant Professor of Medicine
  • Co-Director, The Maria and Alando J. Ballantyne, M.D., Atherosclerosis Clinical Research Laboratory

Contact Information:

Phone: 713-798-3407
Fax: 713-798-7400

Basic and Clinical Research Interests:

Dr. Hoogeveen's basic research interests focus on the molecular biology and biochemistry of sterol and lipid metabolism. Of particular research interest is the role of oxidative stress and dyslipidemia in the etiology of cardiovascular disease and diabetes. Current studies examine the role of oxidatively modified sterols and lipids in the development of cardiovascular disease, diabetes, and the metabolic syndrome. As the Co-Director of The Maria and Alando J. Ballantyne, M.D., Atherosclerosis Clinical Research Laboratory, which serves as the core laboratory for the Atherosclerosis Risk in Communities (ARIC) study, Dr. Hoogeveen is directly involved in assay development. Recent validation studies of a novel assay for lipoprotein-associated phospholipase A2 (Lp-PLA2) in the ARIC study cohort have led to FDA approval for the PLAC-test as a biomarker for cardiovascular risk. The discovery of novel biomarkers might be useful in identifying individuals at high risk for cardiovascular disease, the metabolic syndrome and diabetes.

Selected Publications:

E-mail this page to a friend